Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 302
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04178889 | Second Primary Lung Cancer Cohort Study (SPORT) | ||
| NCT01668550 | A Phase I Study of AZD0424 Alone and in Combination in Advanced Solid Tumours | ||
| NCT02121639 | Open Label Phase I/Randomised,Double Blind Phase II Study in mCRPC of AZD5363 In Combination With DP Chemotherapy | ||
| NCT06320067 | A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer | ||
| NCT05848765 | Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy | ||
| NCT01098344 | MK0752 and Gemcitabine Hydrochloride in Treating Patients With Stage III and IV Pancreatic Cancer That Cannot Be Removed by Surgery | ||
| NCT03150576 | Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer | ||
| NCT05768178 | DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers. | ||
| NCT01222221 | Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | ||
| NCT07172958 | Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE) | ||
| NCT03479151 | Magnetic Resonance Guided High Intensity Focused Ultrasound (MRgHIFU) for Pain Palliation of Bone Metastases | ||
| NCT03527667 | Incentivized Smoking Cessation for Diabetics | ||
| NCT00758056 | Study of Genes and the Environment in Patients With Endometrial Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom | ||
| NCT01719835 | CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II Study | ||
| NCT00427713 | Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer | ||
| NCT02933320 | BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or Leukaemia | ||
| NCT00006476 | Suramin in Treating Patients With Recurrent Bladder Cancer | ||
| NCT00908180 | Carmustine, Etoposide, Cytarabine, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma | ||
| NCT04868227 | Scottish Vitamin D Intervention Study | ||
| NCT00337246 | Combination Chemotherapy With or Without Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia | ||
| NCT00554775 | WBRT & Erlotinib in Advanced NSCLC and Brain Metastases | ||
| NCT04065269 | ATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no Loss | ||
| NCT03994783 | Transplant Antibody-Mediated Rejection: Guiding Effective Treatments | ||
| NCT01303887 | A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly Patients | ||
| NCT01212887 | Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer | ||
| NCT07095517 | Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors | ||
| NCT04523116 | Validation of Tie2 as the First Tumour Vascular Response Biomarker for VEGF Inhibitors: VALTIVE1 | ||
| NCT01104571 | Trastuzumab or Lapatinib Ditosylate in Treating Women With Early Breast Cancer | ||
| NCT00002460 | Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer | ||
| NCT05635344 | A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation for Post-molar Gestational Trophoblastic Neoplasia | ||
| NCT06380816 | A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer | ||
| NCT00433563 | Concurrent Once Daily Versus Twice Daily Radiotherapy for Limited Stage Small Cell Lung Cancer | ||
| NCT04908111 | A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1 | ||
| NCT05255653 | Refining Adjuvant Treatment in Endometrial Cancer Based on Molecular Features | ||
| NCT05554523 | How Does Skin Tone Affect Quantitative Photoacoustic Imaging | ||
| NCT01171378 | Study of Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone (CHOP) With Ofatumumab in Patients With Richter's Syndrome | ||
| NCT04161417 | Precision-Panc Master Protocol: Personalising Treatment for Pancreatic Cancer | ||
| NCT03096054 | A CR-UK Phase I Trial of LY3143921 | ||
| NCT00757965 | Study of Genes and the Environment in Patients With Colorectal Cancer in the East Anglia Region of the United Kingdom | ||
| NCT03466034 | The Role of Hypoxia as a Selective Pressure for TP53 Mutations | ||
| NCT03741426 | WIRE - Novel Treatments in Renal Cell Cancer | ||
| NCT05097274 | The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation. | ||
| NCT00275132 | Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | ||
| NCT01590160 | Ganetespib With Platinum, in Patients With Malignant Pleural Mesothelioma | ||
| NCT01737242 | UK Genetic Prostate Cancer Study: Epidemiology and Molecular Genetics Studies | ||
| NCT02752204 | An Evaluation AZD2014 Alone and in Combination With Rituximab in Relapsed/Refractory Diffuse Large B Cell Lymphoma | ||
| NCT06632236 | 5G-EMERALD: Amivantamab in Malignant Brain Tumours | ||
| NCT05361135 | 18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia | ||
| NCT00748527 | Carboplatin With or Without Decitabine in Treating Patients With Progressive, Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | ||
| NCT02308072 | Phase I Study of Olaparib Combined With Cisplatin-based Chemoradiotherapy to Treat Locally Advanced Head and Neck Cancer |
